Riding a New Wave of Translation
Is the overwhelming focus on genomics and transcriptomics in translational science really the best way to help patients?
Valeria Ossovskaya |
Clinicians, patients and the FDA are pressing biotech and pharma scientists to deliver more thoughtful and comprehensive translational strategies that can help to answer multidimensional clinical questions. This process is constantly hungry for innovation.
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!